FTO and acute kidney injury: Additionally, BMSCs‐EXOControl treatment increased FTO expression and decreased OXSR1 expression in CLP‐induced SA‐AKI mice models, and BMSCs‐EXOCurcumin could further aggravate this effect (Figure 6G).